Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02339389 · ClinicalTrials.gov registry record
Does Maternal Fever During Labor Analgesia Has Any Relationship With Maternal Ventilation?
A clinical trial, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- 57
- Enrollment target
NCT02339389: Completed study, sponsored by Brigham and Women's Hospital.
NCT02339389 is a clinical trial that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 57 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02339389 has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- 57 participants
- Enrollment target
Study Summary
Epidural techniques offer the advantage of being able to titrate the level, density, and duration of the blockade through the use of a catheter and are associated with relative maternal hemodynamic stability. One of the disadvantages, however, include a raise in maternal temperature that is attributed to labor epidural technique. This study will assess if decreased maternal ventilation following induction of labor analgesia causes a raise in temperature.
Primary Outcome
If Maternal Ventilation decreases following labor analgesia at 2 hour and 4 interval
Interventions
- OTHER Labor analgesia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 57 participants |
| Start Date | 2014-08-14 |
| Est. Completion | 2016-09-02 |
What the finished NCT02339389 record still lists
NCT02339389 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 57 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Labor analgesia is the first listed.
NCT02339389 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02339389 about?
NCT02339389 is a clinical study titled "Does Maternal Fever During Labor Analgesia Has Any Relationship With Maternal Ventilation?". Epidural techniques offer the advantage of being able to titrate the level, density, and duration of the blockade through the use of a catheter and are associated with relative maternal hemodynamic stability. One of the disadvantages, however, include a raise in maternal temperature that is attribut...
What is the current status of trial NCT02339389?
This trial is currently completed. The enrollment target is 57 participants. The study started on 2014-08-14. Estimated completion is 2016-09-02.
What interventions are being tested in trial NCT02339389?
The interventions under investigation include: Labor analgesia (OTHER).
Who is sponsoring clinical trial NCT02339389?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03521830 · 57 participants · Phase 2
Nivolumab Alone or Plus Relatlimab or Ipilimumab for Patients With Locally-Advanced Unresectable or Metastatic Basal Cell Carcinoma
- NCT03587701 · 57 participants · Phase 2
Effects of Anakinra in Subjects With Corticosteroid-resistant/Intolerant Meniere's Disease and Autoimmune Inner Ear Disease
- NCT04104126 · 57 participants · NA
Blood Flow Restriction Therapy in Achilles Injury
- NCT04703842 · 57 participants · Phase 1
Modulation of SERCA2a of Intra-myocytic Calcium Trafficking in Heart Failure With Reduced Ejection Fraction
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI